Applications are invited from the eligible candidates for appointment of pharmacists purely on contractual basis, at Central Govt. Health Scheme, Meerut. The details are as under:
Post : Pharmacist
Prima BioMed Ltd, a leading immuno-oncology company, announced that it has entered into a new collaboration agreement with Japan’s CYTLIMIC, a recent spin off from NEC Corporation (NEC), to test a cancer peptide vaccine in combination with IMP321.
Under the new Material Transfer Agreement (MTA) Prima will provide IMP321 for a formulation development targeting a new pre-clinical and clinical development study to be conducted by CYTLIMIC. The development will be funded by CYTLIMIC and the MTA will be revenue generating for Prima
Otonomy, Inc., a biopharmaceutical company, announced positive results from its pivotal phase 3 clinical trial of Otiprio (ciprofloxacin otic suspension) in patients with acute otitis externa (AOE), also known as swimmer's ear.
Mast Therapeutics, Inc.,a publicly traded biopharmaceutical company, and Savara Inc. (Savara), a privately-held emerging specialty pharmaceutical company, announced that the two companies have entered into a definitive merger agreement, under which the stockholders of Savara would become the majority owners of Mast, and the operations of Mast and Savara would be combined. Subject to stockholder approval, the combined company will advance a pipeline of novel inhalation therapies for the treatment of diseases with significant unmet medical needs, featuring three product candidates, each in advanced clinical development.
Aurobindo Pharma Limited is pleased to announce that the company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Levetiracetam in Sodium Chloride Injection, 500 mg/100 mL (5 mg/mL), 1000 mg/100 mL (10 mg/mL), and 1500 mg/100 mL (15 mg/mL) (Single-use bags).